|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/09/22 Commonwealth Income & Gro… VII LP 10-Q 6/30/22 54:2.2M Blueprint/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 452K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K
11: R1 Cover HTML 65K
12: R2 Condensed Balance Sheets HTML 92K
13: R3 Condensed Balance Sheets (Parenthetical) HTML 24K
14: R4 Condensed Statements of Operations HTML 81K
15: R5 Condensed Statement of Partners Capital HTML 48K
16: R6 Condensed Statements of Cash Flow (Unaudited) HTML 41K
17: R7 Business HTML 21K
18: R8 Summary of Significant Accounting Policies HTML 30K
19: R9 Information Technology Medical Technology HTML 44K
Telecommunications Technology Inventory Management
Equipment (Equipment)
20: R10 Investment in COF 2 HTML 28K
21: R11 Related Party Transactions HTML 36K
22: R12 Notes Payable HTML 34K
23: R13 Supplemental Cash Flow Information HTML 24K
24: R14 Commitments and Contingencies HTML 28K
25: R15 Summary of Significant Accounting Policies HTML 38K
(Policies)
26: R16 Summary of Significant Accounting Policies HTML 20K
(Tables)
27: R17 Information Technology Medical Technology HTML 41K
Telecommunications Technology Inventory Management
Equipment (Tables)
28: R18 Investment in COF 2 (Tables) HTML 27K
29: R19 Related Party Transactions (Tables) HTML 34K
30: R20 Notes Payable (Tables) HTML 29K
31: R21 Supplemental Cash Flow Information (Tables) HTML 24K
32: R22 Business (Details Narrative) HTML 23K
33: R23 Summary of Significant Accounting Policies HTML 22K
(Details)
34: R24 Summary of Significant Accounting Policies HTML 21K
(Details Narrative)
35: R25 Information Technology Medical Technology HTML 29K
Telecommunications Technology Inventory Management
Equipment (Details)
36: R26 Information Technology Medical Technology HTML 23K
Telecommunications Technology Inventory Management
Equipment (Details 1)
37: R27 Information Technology Medical Technology HTML 25K
Telecommunications Technology Inventory Management
Equipment (Details 2)
38: R28 Information Technology Medical Technology HTML 25K
Telecommunications Technology Inventory Management
Equipment (Details 3)
39: R29 Information Technology Medical Technology HTML 27K
Telecommunications Technology Inventory Management
Equipment (Details Narrative)
40: R30 Investment in COF 2 (Details) HTML 26K
41: R31 Investment in COF 2 (Details Narrative) HTML 23K
42: R32 Related Party Transactions (Details) HTML 24K
43: R33 Notes Payable (Details) HTML 34K
44: R34 Notes Payable (Details 1) HTML 28K
45: R35 Notes Payable (Details Narrative) HTML 18K
46: R36 Supplemental Cash Flow Information (Details) HTML 18K
47: R37 Supplemental Cash Flow Information (Details 1) HTML 19K
48: R38 Supplemental Cash Flow Information (Details HTML 18K
Narrative)
49: R39 Commitments and Contingencies (Details Narrative) HTML 31K
52: XML IDEA XML File -- Filing Summary XML 94K
50: XML XBRL Instance -- cigf_10q_htm XML 435K
51: EXCEL IDEA Workbook of Financial Reports XLSX 73K
8: EX-101.CAL XBRL Calculations -- cigf-20220630_cal XML 98K
10: EX-101.DEF XBRL Definitions -- cigf-20220630_def XML 103K
7: EX-101.LAB XBRL Labels -- cigf-20220630_lab XML 408K
9: EX-101.PRE XBRL Presentations -- cigf-20220630_pre XML 299K
6: EX-101.SCH XBRL Schema -- cigf-20220630 XSD 106K
53: JSON XBRL Instance as JSON Data -- MetaLinks 175± 237K
54: ZIP XBRL Zipped Folder -- 0001654954-22-012315-xbrl Zip 105K
EXHIBIT 31.2
31.2 RULE 15d-14(a) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, Kimberly A. Springsteen-Abbott, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Commonwealth Income & Growth Fund VII (the Registrant); |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have: |
|
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| (b) | Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| (c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| (d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
| 5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
|
|
| /s/ Kimberly A. Springsteen-Abbott | |
| Kimberly A. Springsteen-Abbott | |
| Principal Financial Officer | |
| September 8, 2022 |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 9/9/22 | None on these Dates | ||
| Filed on: | 9/8/22 | |||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||